Cibc World Markets Corp Replimune Group, Inc. Transaction History
Cibc World Markets Corp
- $12.4 Billion
- Q1 2025
A detailed history of Cibc World Markets Corp transactions in Replimune Group, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 15,211 shares of REPL stock, worth $148,307. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,211Holding current value
$148,307% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding REPL
# of Institutions
172Shares Held
78.5MCall Options Held
69.4KPut Options Held
216K-
Baker Bros. Advisors LP New York, NY11MShares$108 Million1.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$106 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA4.9MShares$47.8 Million5.02% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$46 Million0.0% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$38.1 Million9.21% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $481M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...